Cancer Survivor Cardiomyopathy Detection (CASCADE)
CAncer Survivor CArdiomyopathy DEtection Pilot Study
Sponsor: Florida Heart Research Institute
A observational or N/A phase clinical study on Cancer and Cardiovascular Diseases, this trial is ongoing. The trial is conducted by Florida Heart Research Institute and has accumulated 14 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Aug 2025 — Oct 2025 [monthly]
Recruiting
-
Mar 2025 — Aug 2025 [monthly]
Recruiting
-
Feb 2025 — Mar 2025 [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Jun 2023 — Feb 2024 [monthly]
Recruiting
-
Apr 2023 — Jun 2023 [monthly]
Recruiting
Phase: NA → None
-
Mar 2023 — Apr 2023 [monthly]
Recruiting NA
-
Dec 2022 — Mar 2023 [monthly]
Recruiting NA
-
May 2022 — Dec 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2022 — May 2022 [monthly]
Not Yet Recruiting NA
-
Feb 2022 — Mar 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Florida Heart Research Institute
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .